Hi-Tech Pharmacal in $25 Million Medicaid Settlement

NEW YORK (AP) -- Hi-Tech Pharmacal said Thursday that it will pay $25 million to resolve allegations that it overcharged the Texas Medicaid program.

The Amityville, N.Y., company said it has already set aside money to cover the settlement and is not acknowledging any wrongdoing or liability.

Hi-Tech had said in July that it set aside $15.5 million to cover a potential settlement tied to an investigation by the Texas Health and Human Services Commission into the submission of price information.

Hi-Tech Pharmacal Co. also said Thursday that its shareholders have approved the sale of the company to Akorn and it expects the deal to close by the end of March. Akorn agreed to buy Hi-Tech in August for $640 million. Both companies make generic drugs.

link


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2776469, ~/Articles/ArticleHandler.aspx, 8/2/2014 2:01:32 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement